4.7 Article

Rapid generation of endogenously driven transcriptional reporters in cells through CRISPR/Cas9

Journal

SCIENTIFIC REPORTS
Volume 5, Issue -, Pages -

Publisher

NATURE PORTFOLIO
DOI: 10.1038/srep09811

Keywords

-

Funding

  1. Wellcome Trust [097418/Z/11Z]
  2. CONICYT complementary fellowship [74140018]
  3. MRC studentship
  4. MRC
  5. AstraZeneca
  6. Boehringer-Ingelheim
  7. GlaxoSmithKline
  8. Merck-Serono
  9. Pfizer
  10. Janssen
  11. Cancer Research UK
  12. [098391/Z/12/7]
  13. Medical Research Council [MC_UU_12016/3, G0701194] Funding Source: researchfish
  14. Wellcome Trust [098391/Z/12/Z] Funding Source: researchfish
  15. MRC [G0701194, MC_UU_12016/3] Funding Source: UKRI

Ask authors/readers for more resources

CRISPR/Cas9 technologies have been employed for genome editing to achieve gene knockouts and knock-ins in somatic cells. Similarly, certain endogenous genes have been tagged with fluorescent proteins. Often, the detection of tagged proteins requires high expression and sophisticated tools such as confocal microscopy and flow cytometry. Therefore, a simple, sensitive and robust transcriptional reporter system driven by endogenous promoter for studies into transcriptional regulation is desirable. We report a CRISPR/Cas9-based methodology for rapidly integrating a firefly luciferase gene in somatic cells under the control of endogenous promoter, using the TGF beta-responsive gene PAI-1. Our strategy employed a polycistronic cassette containing a non-fused GFP protein to ensure the detection of transgene delivery and rapid isolation of positive clones. We demonstrate that firefly luciferase cDNA can be efficiently delivered downstream of the promoter of the TGF beta-responsive gene PAI-1. Using chemical and genetic regulators of TGF beta signalling, we show that it mimics the transcriptional regulation of endogenous PAI-1 expression. Our unique approach has the potential to expedite studies on transcription of any gene in the context of its native chromatin landscape in somatic cells, allowing for robust high-throughput chemical and genetic screens.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Multidisciplinary Sciences

Potent neutralization of clinical isolates of SARS-CoV-2 D614 and G614 variants by a monomeric, sub-nanomolar affinity nanobody

Guillermo Valenzuela Nieto, Ronald Jara, Daniel Watterson, Naphak Modhiran, Alberto A. Amarilla, Johanna Himelreichs, Alexander A. Khromykh, Constanza Salinas-Rebolledo, Teresa Pinto, Yorka Cheuquemilla, Yago Margolles, Natalia Lopez Gonzalez del Rey, Zaray Miranda-Chacon, Alexei Cuevas, Anne Berking, Camila Deride, Sebastian Gonzalez-Moraga, Hector Mancilla, Daniel Maturana, Andreas Langer, Juan Pablo Toledo, Ananda Muller, Benjamin Uberti, Paola Krall, Pamela Ehrenfeld, Javier Blesa, Pedro Chana-Cuevas, German Rehren, David Schwefel, Luis Angel Fernandez, Alejandro Rojas-Fernandez

Summary: Despite global efforts to develop SARS-CoV-2 treatments, the urgent need for effective diagnosis, treatment, and prophylactic measures remains critical. The development of alpaca Nanobody W25 shows promise as a potential antiviral agent, efficiently neutralizing SARS-CoV-2 strains with high affinity.

SCIENTIFIC REPORTS (2021)

Article Geriatrics & Gerontology

Lack of Parkinsonian Pathology and Neurodegeneration in Mice After Long-Term Injections of a Proteasome Inhibitor in Olfactory Bulb and Amygdala

Natalia Lopez-Gonzalez del Rey, Tiziano Balzano, Lucia Martin-Rodriguez, Constanza Salinas-Rebolledo, Ines Trigo-Damas, Alejandro Rojas-Fernandez, Lydia Alvarez-Erviti, Javier Blesa

Summary: Proteinaceous inclusions known as LBs are used as a pathological hallmark for PD, with early deposits in the OB and amygdala containing insoluble alpha-synuclein and other ubiquitinated proteins. Injecting lactacystin into the OB and amygdala of mice did not result in significant differences in neuronal numbers, alpha-synuclein expression, or dopaminergic integrity, indicating that long-term injections in extra nigrostriatal regions may not mimic the spreading aspects of PD.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Article Cell Biology

Negative Modulation of Macroautophagy by Stabilized HERPUD1 is Counteracted by an Increased ER-Lysosomal Network With Impact in Drug-Induced Stress Cell Survival

Gabriela Vargas, Omar Cortes, Eloisa Arias-Munoz, Sergio Hernandez, Cristobal Cerda-Troncoso, Laura Hernandez, Alexis E. Gonzalez, Michael H. Tatham, Hianara A. Bustamante, Claudio Retamal, Jorge Cancino, Manuel Varas-Godoy, Ronald T. Hay, Alejandro Rojas-Fernandez, Viviana A. Cavieres, Patricia V. Burgos

Summary: Macroautophagy and the ubiquitin proteasome system are interconnected in maintaining cellular homeostasis. HERPUD1, a protein regulated by proteasomal degradation, stabilizes ER and lysosomal network and negatively regulates autophagy, promoting cell survival under stress conditions.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Biochemistry & Molecular Biology

SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein

Eduardo A. Albornoz, Alberto A. Amarilla, Naphak Modhiran, Sandra Parker, Xaria X. Li, Danushka K. Wijesundara, Julio Aguado, Adriana Pliego Zamora, Christopher L. D. McMillan, Benjamin Liang, Nias Y. G. Peng, Julian D. J. Sng, Fatema Tuj Saima, Jenny N. Fung, John D. Lee, Devina Paramitha, Rhys Parry, Michael S. Avumegah, Ariel Isaacs, Martin W. Lo, Zaray Miranda-Chacon, Daniella Bradshaw, Constanza Salinas-Rebolledo, Niwanthi W. Rajapakse, Ernst J. Wolvetang, Trent P. Munro, Alejandro Rojas-Fernandez, Paul R. Young, Katryn J. Stacey, Alexander A. Khromykh, Keith J. Chappell, Daniel Watterson, Trent M. Woodruff

Summary: COVID-19 infection may lead to neurological symptoms similar to Parkinson's disease. The study found that SARS-CoV-2 and spike protein can directly activate the NLRP3 inflammasome in microglial cells, which may contribute to the development of neuroinflammation.

MOLECULAR PSYCHIATRY (2023)

Review Hematology

Beyond current treatment of Fanconi Anemia: What do advances in cell and gene-based approaches offer?

Elena Martinez-Balsalobre, Jean-Hugues Guervilly, Jenny van Asbeck van der Wijst, Ana Belen Perez-Oliva, Christophe Lachaud

Summary: Fanconi anemia is a rare inherited disorder that affects the bone marrow and leads to decreased production of blood cells. Defective repair of DNA interstrand crosslinks is one of the causes, with mutations in over 20 genes linked to the disease. Advances in science and molecular biology have shed light on the relationship between FA gene mutations and the severity of clinical manifestations. This article highlights the current and promising therapeutic options for this rare disease.

BLOOD REVIEWS (2023)

Article Cell Biology

The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA

Ellis G. Jaffray, Michael H. Tatham, Barbara Mojsa, Magda Liczmanska, Alejandro Rojas-Fernandez, Yili Yin, Graeme Ball, Ronald T. Hay

Summary: Jaffray et al. demonstrated that the degradation of PML and PML-RARA induced by arsenic relies on the VCP/p97 segregase protein. Arsenic trioxide treatment leads to degradation of PML-RARA and PML, curing the disease. The UFD1-NPLOC4-p97 segregase complex is essential for extracting poly-ubiquitinated, poly-SUMOylated PML from PML bodies prior to proteasomal degradation.

JOURNAL OF CELL BIOLOGY (2023)

Article Medicine, Research & Experimental

ZAKa/P38 kinase signaling pathway regulates hematopoiesis by activating the NLRP1 inflammasome

Lola Rodriguez-Ruiz, Juan M. Lozano-Gil, Elena Naranjo-Sanchez, Elena Martinez-Balsalobre, Alicia Martinez-Lopez, Christophe Lachaud, Miguel Blanquer, Toan K. Phung, Diana Garcia-Moreno, Maria L. Cayuela, Sylwia D. Tyrkalska, Ana B. Perez-Oliva, Victoriano Mulero

Summary: Chronic inflammatory diseases are associated with changes in hematopoiesis, including increased neutrophil counts and anemia. The NLRP1 inflammasome regulates hematopoiesis through the cleavage of GATA1, resulting in neutrophil reduction and increased erythrocyte counts. Inhibition of NLRP1 by LRRFIP1 and FLII, along with activation of the ZAKa/P38 kinase axis, promotes erythroid differentiation and offers potential therapeutic targets for hematopoietic alterations associated with chronic inflammatory and rare diseases.

EMBO MOLECULAR MEDICINE (2023)

Article Virology

Adenovirus E1B-55K controls SUMO-dependent degradation of antiviral cellular restriction factors

Wing-Hang Ip, Michael H. Tatham, Steewen Krohne, Julia Gruhne, Michael Melling, Tina Meyer, Britta Gornott, Luca D. Bertzbach, Ronald T. Hay, Estefania Rodriguez, Thomas Dobner

Summary: This study used quantitative SUMO proteomics to analyze the cellular consequences of E1B-55K-mediated host cell modulation and adenovirus infection. The results showed that changes in the SUMOylated proteome could regulate DNA damage response, cell cycle control, chromatin assembly, and gene transcription. Additionally, a SUMO-dependent, ubiquitin-mediated degradation mechanism for some SUMO substrates was identified, suggesting that E1B-55K might use multiple mechanisms to alter restrictive cellular pathways.

JOURNAL OF VIROLOGY (2023)

Article Biochemistry & Molecular Biology

The SUMO-NIP45 pathway processes toxic DNA catenanes to prevent mitotic failure

Emil P. T. Hertz, Ignacio Alonso-de Vega, Thomas Kruse, Yiqing Wang, Ivo A. Hendriks, Anna H. Bizard, Ania Eugui-Anta, Ronald T. Hay, Michael L. Nielsen, Jakob Nilsson, Ian D. Hickson, Niels Mailand

Summary: Hertz et al. use CRISPR screening to identify genetic vulnerabilities to inhibition of SUMOylation in human cells. They show that SUMO exerts its essential role in cell proliferation via NIP45- and BTRR-PICH-mediated DNA catenane resolution pathways. NIP45 mediates a TOP2-independent DNA catenane resolution process through its SUMO-like domains, promoting SUMOylation of specific factors including the SLX4 multi-nuclease complex, which contributes to catenane conversion into DSBs. Their findings establish the importance of SUMOylation in enabling resolution of toxic DNA catenanes via non-epistatic NIP45- and BTRR-PICH-dependent pathways to prevent mitotic failure.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2023)

Article Biochemistry & Molecular Biology

A clickable melphalan for monitoring DNA interstrand crosslink accumulation and detecting ICL repair defects in Fanconi anemia patient cells

Sara Berrada, Elena Martinez-Balsalobre, Lise Larcher, Violette Azzoni, Nadia Vasquez, Melanie Da Costa, Sebastien Abel, Gilles Audoly, Lara Lee, Camille Montersino, Remy Castellano, Sebastien Combes, Camille Gelot, Raphael Ceccaldi, Jean-Hugues Guervilly, Jean Soulier, Christophe Lachaud

Summary: Fanconi anemia (FA) is a genetic disorder that affects DNA interstrand crosslink (ICL) repair. Researchers developed a new tool, click-melphalan, to investigate ICL repair and found that FANCD2 knockout cells are deficient in repairing click-melphalan-induced lesions.

NUCLEIC ACIDS RESEARCH (2023)

Article Cell Biology

Article SUMO protease SENP6 protects the nucleus from hyperSUMOylation-induced laminopathy-like alterations

Magda Liczmanska, Michael H. Tatham, Barbara Mojsa, Ania Eugui-Anta, Alejandro Rojas-Fernandez, Adel F. M. Ibrahim, Ronald T. Hay

Summary: The small ubiquitin-like modifier (SUMO) protease SENP6 disassembles SUMO chains from cellular substrate proteins. Proteins of the lamin family show increased SUMO modification after SENP6 depletion, accompanied by nuclear structural changes similar to laminopathies. Proximity-induced SUMO modification (PISM) directly targets lamin A/C for SUMO conjugation, recapitulating altered nuclear structure after SENP6 depletion. SENP6 activity protects the nucleus against hyperSUMOylation-induced laminopathy-like alterations.

CELL REPORTS (2023)

Article Biochemistry & Molecular Biology

An affinity-directed phosphatase, AdPhosphatase, system for targeted protein dephosphorylation

Luke M. Simpson, Luke J. Fulcher, Gajanan Sathe, Abigail Brewer, Jin-Feng Zhao, Daniel R. Squair, Jennifer Crooks, Melanie Wightman, Nicola T. Wood, Robert Gourlay, Joby Varghese, Renata F. Soares, Gopal P. Sapkota

Summary: Reversible protein phosphorylation is crucial for controlling protein function and intracellular signaling. This study presents the development and application of the AdPhosphatase system, which allows targeted dephosphorylation of specific phospho-substrates. By using antigen-stabilized anti-GFP nanobody conjugated with Protein Phosphatase 1 or 2A catalytic subunits, the researchers successfully achieved specific dephosphorylation of two phospho-proteins, FAM83D and ULK1, with exquisite specificity. AdPhosphatase provides a new modality for potential drug discovery approaches by altering the phospho-status and function of target proteins.

CELL CHEMICAL BIOLOGY (2023)

Article Biochemistry & Molecular Biology

Target protein localization and its impact on PROTAC-mediated degradation

Luke M. Simpson, Lorraine Glennie, Abigail Brewer, Jin-Feng Zhao, Jennifer Crooks, Natalia Shpiro, Gopal P. Sapkota

Summary: This study investigates whether the subcellular context of a protein of interest (POI) affects the efficacy of PROTAC-mediated protein degradation. The results suggest that the subcellular localization of the POI can influence the effectiveness of PROTAC-induced POI degradation.

CELL CHEMICAL BIOLOGY (2022)

Meeting Abstract Hematology

INTEGRATIVE MULTI-OMICS ANALYSIS FOR UNDERSTANDING ACUTE PROMYELOCYTIC LEUKEMIA RESISTANCE: EZH2 ON THE ROAD

Mathilde Poplineau, Leonard Herault, Adrien Mazuel, Nadine Platet, Shuhei Koide, Wakako Kuribayashi, Nadine Carbuccia, Lia N'Guyen, Julien Vernerey, Motohiko Oshima, Daniel Birnbaum, Christophe Lachaud, Atsushi Iwama, Estelle Duprez

EXPERIMENTAL HEMATOLOGY (2021)

No Data Available